Pillar Biosciences Incorporated

About Pillar Biosciences Incorporated

Pillar Biosciences is a global innovator in next-generation sequencing (NGS), focused on delivering kitted NGS solutions designed for robust analytical performance and operational efficiency. Through its proprietary SLIMamp® and PiVAT® technologies, Pillar enables high analytical performance NGS testing at the point of need, delivering operational efficiency and broader access to advanced molecular diagnostics worldwide. Pillar’s broad portfolio includes more than 20 NGS testing kits available in both IVD and RUO formats, designed to target a broad range of applications including tumor profiling, actionable biomarker detection and analysis, molecular research, and monitoring applications. These solutions are engineered for efficiency and scalability, allowing laboratories to perform complex testing closer to the patient while maintaining reliable analytical performance. By localizing NGS testing, Pillar Biosciences helps address barriers to access, including logistics, infrastructure limitations, and long turnaround times associated with centralized testing. The company partners with laboratories, clinicians, and industry stakeholders to provide reliable implementation, quality practices, and workflow optimization across diverse settings. Pillar is also focused on supporting biopharmaceutical partnerships for companion diagnostic (CDx) development, helping align biomarker strategies with scalable, high-performance NGS testing. With a commitment to innovation, quality, and collaboration, Pillar continues to advance molecular diagnostics, providing laboratories and clinicians with meaningful insights that advance precision oncology research and routine clinical workflows worldwide.